TB Dispensary Arkhangelsk, Northern Russia
In Russia, MSF is collaborating with health authorities and academic partners in Arkhangelsk region to reduce the burden of drug-resistant tuberculosis and improve treatment for the disease.

In 2019, our teams in Arkhangelsk region began providing drugs and technical advice to support the treatment of patients with the most severe forms of TB in line with the latest World Health Organization recommendations. We are currently supporting the treatment of dozens of patients.

In partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University and Arkhangelsk Clinical TB Dispensary, we are building on existing expertise and working together to implement new all-oral short-course regimens. The aim of the collaboration is to provide evidence for future developments in TB policy in Russia and increase the availability of more effective models of treatment.  

MSF teams are also responding to the COVID-19 pandemic.

Our teams have been working in Russia since the early 1990s, running programmes in Moscow, Saint Petersburg, Kemerovo region, Chechnya, Ingushetia and Dagestan. 


Chechen displaced: MSF open letter to OCHA

Project Update 30 Jul 2002

Chechen displaced remain under pressure

Project Update 26 Jul 2002

MSF condemns relocation of displaced Chechens

Press Release 9 Jul 2002

MSF active in the three worst hit regions as well as in IDP camps in Ingushetia and Chechnya.

Project Update 27 Jun 2002

Letter to Danish Foreign Minister on the repatriation of Chechen IDPs in Ingushetia

Project Update 10 Jun 2002

MSF concerned over new pressures exerted on Chechen refugees inIngushetia to return to Chechnya

Press Release 4 Jun 2002

Contact us

TB treatments yield promising results in the Chechen Republic
MSF Moscow

16 Malaya Dmitrovka street,
127006 Moscow,
Russian Federation